TRIAL DETAIL
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma |
|||
NCT#: |
||||
Conditions: |
Brain and Central Nervous System Tumors; Gastrointestinal Stromal Tumor; Ovarian Cancer; Sarcoma; Small Intestine Cancer |
|||
Status: |
Completed |
|||
Phase: |
2 |
Start Date |
Age of Trial (yrs) |
|
Treatment Phase: |
First-line |
|||
Drug Category: |
Chemotherapy |
|||
Strategy: |
Traditional chemotherapy |
|||
Trial Type: |
Specifically GIST plus other cancers |
|||
Other Protocol IDs: |
CDR0000067132, EORTC-62982 |
|||
Sponsor: |
EORTC |
|||
Patient Contact: |
||||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Intravenous |
|||
Trial Notes: |
This study is ongoing but not recruiting new patients. Results reported in 2004 suggest that it is not an effective treatment for advanced GIST. |
|||
Trial Links |
Trial Results |
Drug Information |
| NCI Drug Dictionary |
| Full text article- PK and PD of the novel marine-derived anticancer agent Ecteinascidin 743 in a phase I dose-finding study |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |